Medical contributor
Marisa Holubar, MD, MS, FIDSA
Clinical Professor of Infectious Diseases; Medical Director, Stanford Antimicrobial Safety and Sustainability Program; Co-Director, WHO Collaborating Center for Antimicrobial Stewardship
Stanford Medicine
This profile connects Marisa Holubar’s documented infectious-disease work with antimicrobial stewardship and antibiotic safety. It records no completed Glacier EMS page review, staff appointment, or treatment relationship.
Verified biography
Marisa Holubar, MD, MS, FIDSA, is a Clinical Professor of Infectious Diseases at Stanford, Medical Director of the Stanford Antimicrobial Safety and Sustainability Program and Co-Director of the WHO Collaborating Center for Antimicrobial Stewardship.
Clinical Professor of Medicine (Infectious Diseases), Stanford; Fellow of IDSA since 2023; Interim Division Co-Chief, Infectious Diseases and Geographic Medicine since 2024; Medical Director, Stanford Antimicrobial Safety and Sustainability Program since 2021; Co-director, WHO Collaborating Center for Antimicrobial Stewardship since 2019.
Education and program leadership
Current affiliation: Stanford Medicine
Current title: Clinical Professor of Infectious Diseases; Medical Director, Stanford Antimicrobial Safety and Sustainability Program; Co-Director, WHO Collaborating Center for Antimicrobial Stewardship
- MD, University of Wisconsin School of Medicine, 2005
- Residency, Brown University School of Medicine, 2009
- Fellowship, Stanford, 2013
- MS in Epidemiology and Clinical Research, Stanford, 2014
- Board certification, Internal Medicine, ABIM, 2009
- Board certification, Infectious Disease, ABIM, 2024
Antibiotic safety and stewardship
- Antimicrobial stewardship
- Infectious diseases
- Antibiotic safety